Peptide Blends 101: What Is Actually in the Vial?

A label names two peptides. Did the test measure both? A plain-English guide to identity, purity, quantity and finished-blend testing.
A Depot Is More Than Its API

Why long-acting peptide quality takes more than one number: assay, particles, residual solvents, degradation, and release behavior answer different questions.
The Retatrutide Black Market Just Got Real: What the First Lab Data Actually Shows
Only one of eighteen black-market retatrutide vials matched its label. The first published chemical analysis explains why that number should surprise you, and what it would take to actually verify one of these vials.
The Identity Problem: What IS BPC-157?

The FDA’s advisory panel voted to recommend BPC-157 for compounding. But their own scientists raised a question that matters more than the vote itself: What IS BPC-157?
The Oral Peptide Breakthrough: What Enlicitide Teaches Us About Testing

FDA’s approval of enlicitide, the first oral PCSK9 inhibitor, shows why macrocyclic peptide structure, formulation, and fit-for-purpose analytical testing must be interpreted as one connected system.
Same Name, Different Chemical: The Hidden Salt-Form Trap in Peptide Testing

FDA’s July 2026 peptide briefing documents expose a critical testing issue: a common peptide name may not identify its salt form, assay basis, or true peptide content.
Silicon Valley’s Unapproved ‘Godzilla’: The Retatrutide Phenomenon and the Testing Crisis It Created

Tech elites are injecting an unapproved triple agonist sourced from the grey market. Here’s why that’s an analytical nightmare, and what rigorous testing reveals.
The Gray Market’s Crypto Pipeline: From Fentanyl Precursors to Peptides

A bombshell Chainalysis report reveals the $100 million crypto pipeline fueling gray-market peptides and its alarming connection to fentanyl precursor manufacturers. Here’s what the collapse of independent testing means for consumer safety.
What’s Actually In Your Cream? The 5 Tests Every Topical Should Pass

A 2026 eczema cream recall traced to Staphylococcus aureus shows what can go wrong with topicals. The five tests every cream, lotion or serum should pass.
When States Draw the Line: The New Era of State-Level Peptide Enforcement

States are starting to enforce their own rules on peptide therapy. What the new state actions mean for clinics and why analytical verification matters.